assisted living; hyperbaric oxygen therapy

SB 1052 allows Arizona assisted living homes and centers to offer mild hyperbaric oxygen therapy to residents using FDA-cleared home-use chambers. It requires therapy to be provided only under a physician's order, with trained staff present during sessions, and mandates facilities to give residents a notice explaining the FDA-approved uses (limited to mild symptoms like acute mountain sickness) and risks of off-label use. The bill prohibits offering this therapy to residents needing directed care without specific physician approval and written informed consent. This directly affects assisted living facilities and their residents by establishing new safety and transparency requirements for this therapy.